openPR Logo
Press release

Recombinant Human Interferon Protein Market Shares, Strategies and Forecast Worldwide, 2018 to 2027(Based on type, the global recombinant human interferon protein market is segmented as: Gamma inhibitors Alpha inhibitors Others)

02-26-2019 01:57 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Recombinant Human Interferon Protein Market Shares,

Recombinant human interferon protein (IFN-y) is a bioactive protein primarily used for cell culture applications in many diagnostic laboratories. It is currently being used in many research activities such as immunology, oncology, stem cell research and virology. Recombinant human interferon proteins are not just limited to the process of discharging of reactive oxygen species. They are also involved in other growth functions such as bone growth and bone resorption. Recombinant human interferon protein is one of the recombinant proteins available currently, the only difference is that it is sourced from CHO-cell line. Common practice to such medium is associated with complications which might lead to failure in cell cultures. The status of recombinant human interferon protein is strictly regulated as it require strict temperature control, which is around -70°C or below for retaining full action activity. Recombinant human interferon protein is mostly available in beta and alpha form, though other forms have started emerging in the market.

Recombinant Human Interferon Protein Market: Drivers and Restraints

Recombinant human interferon protein is principally studied on the protein production, it is probably going to strike the intensive research and development sector. The adoption of recombinant human interferon protein started with the advancement in the field of molecular biology. The marketing of these proteins started in the late nineties with the U.S. observing the highest success rates. Most of the proteins require specific conditions in order to be in an active state for clinical study, and a large portion is still used in clinical research for developing counter actions. The trends supporting the entire recombinant therapeutics are expected to influence the growth of the market. Though the effectiveness of recombinant human interferon proteins is still debatable with other species induced, recombinant proteins are being used in general applications. However, high cost that can go for around US$ 170 for a 5 µg pack is expected to be a major factor retraining the growth of the market. Some of the major blockbuster products from big companies are well established in the developed countries.

Click here to subscribe Sample @ 

Recombinant Human Interferon Protein Market: Segmentation

Tentatively, the global recombinant human interferon protein market can be segmented on the basis of type, end user and geography.

Based on type, the global recombinant human interferon protein market is segmented as:

Gamma inhibitors
Alpha inhibitors
Based on end user, the global recombinant human interferon protein is segmented as:

Diagnostic Laboratories
Research Laboratories
Recombinant Human Interferon Protein Market: Overview

The global market for recombinant human interferon protein is expected to witness steady growth over the forecast period due to rise of molecular biology in most of the disease applications. The growth of the market is related to the rising number of cancer cases, which is mostly observed in cases of growth defect.

Recombinant Human Interferon Protein Market: Regional Outlook

Geographically, the global recombinant human interferon protein market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant regional market for recombinant human interferon protein owing to increasing number of research activities in the region. The recombinant human interferon protein market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to product development and expansion by key players. Europe is expected to hold a large share in the global recombinant human interferon protein market throughout the forecast period due to its quality healthcare facilities and modern outlook for recombinant human Interferon protein.

Recombinant Human Interferon Protein Market: Key Players

The global market for recombinant human interferon protein is highly fragmented. Examples of some of the key players operating in the global recombinant human interferon protein market are Merck KGaA, Abcam plc, R&D Systems, Thermo Fisher Scientific, BioLegend, Invitrogen, OriGene, and Biorbyt, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request/View TOC@ 

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain 
Regional analysis includes

North America
Latin America
Rest of LatAm 
EU – 4 (Germany, France, Italy, Spain)
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep. etc.)
Rest of Europe 
CIS & Russia 
Greater China
ASEAN Countries
Rest of APEJ 
Middle East & Africa
GCC Countries
South Africa
Rest of MEA    
Report Highlights: 

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Grow Your Business From Expert Advice: 

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Read Industry News at -

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant Human Interferon Protein Market Shares, Strategies and Forecast Worldwide, 2018 to 2027(Based on type, the global recombinant human interferon protein market is segmented as: Gamma inhibitors Alpha inhibitors Others) here

News-ID: 1618044 • Views: 133

More Releases from Fact.MR

07-02-2020 | Health & Medicine
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
06-02-2020 | Health & Medicine
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online
03-20-2020 | Health & Medicine
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On

All 5 Releases

More Releases for Recombinant

Global Recombinant Factor VIII Market Research Report
This report studies the global Recombinant Factor VIII market status and forecast, categorizes the global Recombinant Factor VIII market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Shire (Baxter) Bayer CSL Pfizer Biogen Octapharma NovoNordisk Geographically, this report studies the top producers
United States Recombinant Vaccine Market Report
In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
Recombinant DNA Technology Market -
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have
Global Human Recombinant Insulin Market – Industry Insights
Discovery of insulin is considered to be one of the most important events in the history of the diabetes treatment. Furthermore, major advances in human insulin technology is the synthesis of human insulin analogue by recombinant technology. Currently, human insulin delivery system available for the administration of insulin include insulin syringes, insulin pumps, jet injections, and pens. Key players are focused on developing recombinant human insulin instead of animal-based insulin,
Global Human Recombinant Insulin Market – Industry Insights
Various government and private research organizations are engaged research and development activities for developing advanced treatment in diabetes care to increase the effectiveness of human insulin, reduce diabetes burden, and minimize the risk of diabetes associated disorders such as diabetes-associated blindness, kidney disease, heart attacks, strokes or limb loss. For instance, American Diabetes Association (ADA) invested US$ 807.4 million in more than 4,700 research projects in diabetes research since 1952
Recombinant Vaccines Market Industry Forecast till 2025
Recombinant vaccines are produced by using recombinant DNA technology or genetic engineering for the prevention of lethal diseases in human beings and animals. Recombinant vaccine is a biological preparation that provides active acquired immunity against a certain disease. Whereas individual being vaccinated produces antibodies against the protein antigen that protect a person from contracting the disease upon attack from the pathogenic microorganism. These vaccines functions on the immune response for